Table 2.

Univariate assessment of continuous predictors in detecting ≥ stage 2 fibrosis in UCSD-NAFLD Cohort

Variable:	AUROC (95% CI)	OR[39] (95% CI)
MRE	0.93 (0.90-0.97)	13.60 (6.71-27.56)
FIB - 4	0.78 (0.71-0.85)	4.36 (2.72-7.00)
AST	0.75 (0.68-0.83)	1.03 (1.02-1.05)
Age	0.66 (0.58-0.73)	1.05 (1.02-1.07)
Platelet count	0.64 (0.55-0.72)	0.99 (0.99-1.00)
ALT	0.60 (0.52-0.68)	1.01 (1.00-1.01)

Abbreviations: ALT, alanine transaminase; AST, aspartate transaminase; AUROC, area under the receiver operating characteristic curve; FIB-4, fibrosis-4 score; MRE, magnetic resonance elastography; NAFLD, non-alcoholic fatty liver disease; UCSD, University of California at San Diego

[39] Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003;56:1129-35.